Search
D-Asparagine
go.drugbank.com/drugs/DB03943Experimental(From Concise Encyclopedia Biochemistry and Molecular Biology, 3rd ed) … A non-essential amino acid that is involved in the metabolic control of cell functions in nerve and brain tissue. It is biosynthesized from ASPARTIC ACID and AMMONIA by asparagine synthetase.
Fluoride ion
go.drugbank.com/drugs/DB11257ApprovedInvestigationalIt is considered a trace element. Fluoride ions are found in various minerals but are only present in trace amounts in water. … It also plays an essential physiological role, such as enhancing the resistance profile and strength of the surface tooth enamel.
Mixtures: ADDAMEL NMyrothecium verrucaria
go.drugbank.com/drugs/DB10819ApprovedMyrothecium verrucaria extract is used in allergenic testing.
Mixtures: Treatment Set TS128871Microsporum audouinii
go.drugbank.com/drugs/DB10842ApprovedMicrosporum audouinii extract is used in allergenic testing.
Mixtures: Treatment Set TS128871Tetracoccosporium paxianum
go.drugbank.com/drugs/DB10849ApprovedTetracoccosporium paxianum extract is used in allergenic testing.
Mixtures: Treatment Set TS128871Emricasan
go.drugbank.com/drugs/DB05408InvestigationalIt is developed by Pfizer and made in such a way that it protects liver cells from excessive apoptosis. … Emricasan is the first caspase inhibitor tested in human which has received orphan drug status by FDA.
Coral snake (micrurus fulvius) immune globulin antivenin (equine)
go.drugbank.com/drugs/DB13883ApprovedIt is intravenously administered so that the antivenin binds to and neutralizes coral snake venom.
Juglans californica pollen
go.drugbank.com/drugs/DB10397ApprovedJuglans californica pollen is mainly used in allergenic testing.
Mixtures: Treatment Set TS333001Filgotinib
go.drugbank.com/drugs/DB14845ApprovedInvestigational[A189165] Non-selective JAK inhibitors like [tofacitinib] target JAK1 and JAK3 subtypes with minimal activity at JAK2. In contrast, the newly approved filgotinib is a highly selective JAK1 inhibitor. … Rheumatoid arthritis (RA) is a chronic, autoimmune, systemic, and inflammatory disease that causes synovial joint symptoms and can limit range of motion in severe cases.
Incadronic acid
go.drugbank.com/drugs/DB06255ExperimentalAlong with being investigated to treat hypercalcemia of malignancy,[A202862] it has also been investigated in the treatment of myeloma, leukemia, and other cancers. … [A14426,A14431,A14427,A202769] Incadronic acid was first described in the literature in 1991.[A202289]